One protein component of this substance is a binding partner of DMBT1. This substance is believed to have some innate immune function due to the presence of collectins SP-A and SP-D in it.  Synthetic versions of this substance include Venticute and KL-4. The production of this substance can be assayed by measuring the lecithin-to-sphingomyelin ratio of amniotic fluid, and its production can be accelerated by cortisol. This substance primarily contains DPPC and other phospholipids. This substance prevents atelectasis [at-UH-lec-tuh-sis], and a condition in which this co
One protein component of this substance is a binding partner of DMBT1. This substance is believed to have some innate immune function due to the presence of collectins SP-A and SP-D in it.  Synthetic versions of this substance include Venticute and KL-4. The production of this substance can be assayed by measuring the lecithin-to-sphingomyelin ratio of amniotic fluid, and its production can be accelerated by cortisol. This substance primarily contains DPPC and other phospholipids. This substance prevents atelectasis [at-UH-lec-tuh-sis], and a condition in which this compound is insufficiently produced shows characteristic hyaline membranes on autopsy and is known as infantile RDS. This substance is often under-produced in premature infants, leading to the collapse of alveoli. For 10 points, name this surface-tension-lowering substance important for lung function.
One protein component of this substance is a binding partner of DMBT1.
Lung surfactant